Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Çã¼ÁƾÁÖ - »õâ
|
F.Hoffmann-La Roche |
E01840531 | Trastuzumab | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
|
Çã¼ÁƾÁÖ150mg - »õâ
|
F.Hoffmann-La Roche |
E01840761 | Trastuzumab | Àü¹®ÀǾàǰ | ±Þ¿© |
| Herceptin |
A type of monoclonal antibody used to detect or treat some types of cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Herceptin blocks the effects of the growth factor protein HER2, which transmits growth signals to breast cancer cells. Also called trastuzumab.
Ãâó: www.stjude.org/glossary
|
|---|---|
| Herceptin |
A new, targeted gene therapy drug.
Ãâó: oes.mans.eun.eg/Courses/med/surgery/graphics/cf_st...
|
| Herceptin |
is a humanized antibody that binds to the HER2/neu cancer associated antigen to treat breast cancer.
Ãâó: www.ariusresearch.com/glos.html
|
| Herceptin |
herceptin is designed to block a protein receptor called her2 that is produced in excess amounts in some women with breast cancer. first monoclonal antibody to fight metastatic breast cancer, to slow the progression of cancer and causes tumor shrinkage.
Ãâó: ipp.boku.ac.at/pz/ref/glossar1.html
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|